publication venue for
- Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.. 42. 2023
- The immune landscape of solid pediatric tumors.. 41. 2022
- MicroRNA-7 as a potential therapeutic target for aberrant NF-κB-driven distant metastasis of gastric cancer.. 38. 2019
- AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models.. 33. 2014
- EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.. 32. 2013
- Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.. 29. 2010
- Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract.. 28. 2009